How does AMBS plan on paying for the Eltoprazine Phase 2b trial? Management has said very little about that, something that has been curious to me. In one of the recent Conference Calls Dr. Lowe mentioned that after we file the IND that we would the apply for some grants. But he said it in a very casual way.

Is it possible that we already have an agreement with the MJF Foundation for them to either help fund or partner with us on Eltoprazine?

Is it possible that AMBS and Fox didn't want that information to be disclosed publicly? I don't know, I am asking if anyone has more thoughts on this.

Warp, even though we fight all the time, you did a good job interpreting the SEC document today. What are your thoughts about the funding of Eltoprazine?